Chembio Diagnostics Inc.

3.49-0.1200-3.32%Vol 492.55K1Y Perf -71.37%
Apr 19th, 2021 12:20 DELAYED
BID3.48 ASK3.49
Open3.59 Previous Close3.61
Pre-Market- After-Market-
 - -%  - -
Target Price
8.33 
Analyst Rating
Strong Buy 1.25
Potential %
140.06 
Finscreener Ranking
★★★+     52.89
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     43.55
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     45.28
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap70.44M 
Earnings Rating
Buy
Price Range Ratio 52W %
3.73 
Earnings Date
3rd May 2021

Today's Price Range

3.463.65

52W Range

3.0115.89

5 Year PE Ratio Range

-15.50-6.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-11.74%
1 Month
-18.33%
3 Months
-38.92%
6 Months
-25.57%
1 Year
-71.37%
3 Years
-54.88%
5 Years
-47.68%
10 Years
-16.44%

TickerPriceChg.Chg.%
CEMI3.49-0.1200-3.32
AAPL134.460.30000.22
GOOG2 299.691.93000.08
MSFT259.00-1.7400-0.67
XOM56.24-0.4200-0.74
WFC43.930.09000.21
JNJ162.920.68000.42
FB302.62-3.5600-1.16
GE13.35-0.0400-0.30
JPM153.09-0.2100-0.14
Financial StrengthValueIndustryS&P 500US Markets
2.10
3.20
0.47
0.91
-8.10
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
21.60
-76.00
-67.10
-44.70
-87.45
RevenueValueIndustryS&P 500US Markets
23.59M
1.17
5.91
10.08
Earnings HistoryEstimateReportedSurprise %
Q04 2020--0.35-
Q03 2020-0.24-0.28-16.67
Q02 2020-0.41-0.402.44
Q01 2020-0.22-0.25-13.64
Q04 2019-0.25-0.238.00
Q03 2019-0.19-0.22-15.79
Q02 2019-0.16-0.19-18.75
Q01 2019-0.14-0.140.00
Earnings Per EndEstimateRevision %Trend
12/2020 QR-0.330.00-
3/2021 QR-0.3066.29Positive
12/2021 FY-1.09--
12/2022 FY-0.94--
Next Report Date3rd May 2021
Estimated EPS Next Report-0.30
Estimates Count1
EPS Growth Next 5 Years %15.00
Volume Overview
Volume492.55K
Shares Outstanding20.18M
Trades Count2.48K
Dollar Volume4.12M
Avg. Volume4.81M
Avg. Weekly Volume805.77K
Avg. Monthly Volume15.06M
Avg. Quarterly Volume5.45M

Chembio Diagnostics Inc. (NASDAQ: CEMI) stock closed at 3.61 per share at the end of the most recent trading day (a -3.48% change compared to the prior day closing price) with a volume of 666.03K shares and market capitalization of 70.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 324 people. Chembio Diagnostics Inc. CEO is Richard L. Eberly.

The one-year performance of Chembio Diagnostics Inc. stock is -71.37%, while year-to-date (YTD) performance is -24%. CEMI stock has a five-year performance of -47.68%. Its 52-week range is between 3.01 and 15.89, which gives CEMI stock a 52-week price range ratio of 3.73%

Chembio Diagnostics Inc. currently has a PE ratio of -3.30, a price-to-book (PB) ratio of 3.20, a price-to-sale (PS) ratio of 3.32, a price to cashflow ratio of 649.30, a PEG ratio of 2.32, a ROA of -40.65%, a ROC of -40.45% and a ROE of -94.62%. The company’s profit margin is -87.45%, its EBITDA margin is -67.10%, and its revenue ttm is $23.59 Million , which makes it $1.17 revenue per share.

Of the last four earnings reports from Chembio Diagnostics Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. Chembio Diagnostics Inc.’s next earnings report date is 03rd May 2021.

The consensus rating of Wall Street analysts for Chembio Diagnostics Inc. is Strong Buy (1.25), with a target price of $8.33, which is +140.06% compared to the current price. The earnings rating for Chembio Diagnostics Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chembio Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Chembio Diagnostics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 23.14, ATR14 : 0.49, CCI20 : -64.78, Chaikin Money Flow : -0.03, MACD : -0.71, Money Flow Index : 92.61, ROC : 6.18, RSI : 28.92, STOCH (14,3) : 9.59, STOCH RSI : 0.00, UO : 35.75, Williams %R : -90.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chembio Diagnostics Inc. in the last 12-months were: Richard L. Eberly (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
2 (66.67 %)
1 (50.00 %)
Moderate Buy
1 (25.00 %)
1 (33.33 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.25
Strong Buy
1.33
Strong Buy
1.50

Chembio Diagnostics Inc.

Chembio Diagnostics Inc is a US-based company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

CEO: Richard L. Eberly

Telephone: +1 631 924-1135

Address: 555 Wireless Boulevard, Hauppauge 11788, NY, US

Number of employees: 324

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

48%52%

Bearish Bullish

57%43%

News

Stocktwits